Hence, it is interesting to evaluate the anti-cancer potential properties of the 1,4-pentadiene-3-one on colon cancer cells carrying KRAS mutation and exhibit molecular phenotypes of chromosomal instability (CIN) [51] that accounts 85% of all sporadic CRCs [52,53]. The gene discussed is KRAS; the disease is malignant colon neoplasm.